Privi Speciality Chemicals quarterly results

Q2 FY27 · Jul–Sep 2026

₹ crore	Q2 FY27	Q2 FY26	Change
Revenue	760	679	+12.0%
EBITDA	200	182	+9.7%
EBITDA margin	26.3%	26.8%	−0.6 pts
Profit before tax	159	125	+26.8%
Net profit	118	90.2	+30.3%
EPS	₹29.96	₹24.04	+24.6%

Every quarter

₹ crore except per share

Tap a line for its trend	Q2 FY27Sep 2026	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Earlier quartersAlpha Plus

Expenses
	760	666	722	605	679	559	614	491	533	464	484	404	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	12.7	15.2	4.2	6.5	0.1	9.0	14.8	2.2	4.5	2.7	7.6	5.6
	773	681	726	611	679	568	628	493	537	467	492	409
	421	397	358	320	372	306	319	299	308	245	230	228
	0.0	1.7	0.0	0.0	0.0	1.5	0.0	0.0	1.5	0.0	0.0	2.1
	−16.7	−26.9	47.6	−18.3	−37.4	−32.0	21.8	−61.3	−17.7	15.2	45.1	−18.1
	29.8	29.9	25.1	33.2	29.0	27.4	23.5	22.0	20.8	20.2	18.0	18.8
	16.9	16.7	18.2	18.6	21.5	23.7	22.6	21.8	21.5	22.0	25.1	24.1
	37.0	37.4	36.5	35.5	35.6	36.2	34.9	32.3	32.4	32.1	29.6	32.4
	126	112	111	118	133	124	117	118	109	88.8	99.9	82.8
	615	568	596	507	554	487	538	432	477	424	448	370
	200	152	180	151	182	132	133	113	110	94.4	91.0	90.0
	163	115	144	116	146	95.9	97.7	80.5	77.8	62.2	61.4	57.5
Profit
	159	113	130	104	125	81.2	89.9	60.9	60.8	42.9	44.0	39.1
	159	113	130	104	125	81.2	89.9	60.9	60.8	42.9	44.0	39.1
	42.1	30.2	34.5	29.0	35.5	24.9	25.2	16.4	16.0	11.0	10.3	10.2
	−1.1	0.3	1.1	−0.0	−0.6	−1.3	0.8	0.1	−0.1	0.5	1.7	0.1
	41.0	30.5	35.6	28.9	34.9	23.6	26.0	16.4	15.9	11.5	12.1	10.3
	118	82.8	94.1	74.9	90.2	57.6	64.0	44.5	44.8	31.5	31.9	28.8
	118	82.8	94.1	74.9	90.2	57.6	64.0	44.5	44.8	31.5	31.9	28.8
	0.2	0.4	1.6	−0.8	0.7	−0.5	−0.4	0.5	−0.2	−0.1	0.1	−1.5
	118	83.2	95.7	74.1	90.9	57.1	63.6	45.0	44.7	31.4	32.0	27.2
	117	84.2	94.1	78.0	—	61.9	—	44.4	44.7	31.5	31.9	27.2
	0.5	−1.4	0.0	−3.1	0.0	−4.4	0.0	0.0	0.2	0.0	0.0	0.0
Per share
	₹29.96	₹21.56	₹23.99	₹19.97	₹24.04	₹15.85	₹17.03	₹11.38	₹11.43	₹8.05	₹8.16	₹7.37
	₹29.96	₹0.00	₹23.99	₹19.97	₹24.04	₹15.85	₹0.00	₹11.38	₹11.43	₹8.05	₹8.16	₹7.37
Other comprehensive income — detail
	0.2	0.4	1.6	−0.8	0.7	−0.5	−0.4	—	—	—	—	—
	0.1	0.1	0.6	−1.3	−0.8	−0.7	−0.6	−0.1	−0.2	−0.1	0.1	0.1
	0.0	0.0	0.2	−0.3	−0.2	−0.2	−0.1	—	—	—	—	—
	—	—	—	—	—	—	—	0.0	0.0	0.0	0.0	0.0
	0.1	0.3	1.1	0.2	1.3	0.0	0.0	0.5	0.1	0.0	0.0	−1.7
	117	84.6	95.3	77.2	94.6	61.5	66.1	44.9	44.5	31.3	31.1	—
	0.5	−1.4	0.4	−3.1	−3.7	−4.4	−2.5	0.0	0.2	0.1	0.8	—
Per share — as-filed variants
	₹29.96	₹21.56	₹23.99	₹19.97	₹24.04	₹15.85	₹17.03	₹11.38	₹11.43	₹8.05	₹8.16	₹7.37
	₹29.96	₹0.00	₹23.99	₹19.97	₹24.04	₹15.85	₹0.00	₹11.38	₹11.43	₹8.05	₹8.16	₹7.37
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	356	295	316	303	344	284	273	253	240	203	209	192
	46.8%	44.2%	43.8%	50.1%	50.7%	50.7%	44.5%	51.5%	45.1%	43.8%	43.1%	47.5%
Adjusted (ex-exceptional items) — derived
	159	113	130	104	125	81.2	89.9	60.9	60.8	42.9	44.0	39.1
	118	82.8	94.1	74.9	90.2	57.6	64.0	44.5	44.8	31.5	31.9	28.8
	₹29.96	₹21.56	₹23.99	₹19.97	₹24.04	₹15.85	₹17.03	₹11.38	₹11.43	₹8.05	₹8.16	₹7.37

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

PRIVISCL₹3,296.30

Privi Speciality Chemicals Ltd.

· Chemicals

Annual Quarterly₹ CrorePeersAARTIIND RAIN RALLIS RCF NFL REFEX NEOGEN LXCHEMMcap ₹12,876 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 30/09/2026
Revenue from Operations	403.8	484.3	464.0	532.8	490.9	613.6	558.8	678.7	604.6	721.5	666.2	760.5
Other Income	5.6	7.6	2.7	4.5	2.2	14.8	9.0	0.1	6.5	4.2	15.2	12.7
Total Income	409.4	491.9	466.7	537.3	493.1	628.4	567.8	678.8	611.1	725.7	681.4	773.2
Expenses
+ Cost of Materials Consumed	228.1	230.4	245.5	308.5	299.3	318.7	305.8	371.7	320.2	358.0	396.9	421.5
+ Purchases of Stock-in-Trade	2.1	0.0	0.0	1.5	0.0	0.0	1.5	0.0	0.0	0.0	1.7	0.0
+ Changes in Inventories	-18.1	45.1	15.2	-17.7	-61.3	21.8	-32.0	-37.4	-18.3	47.6	-26.9	-16.7
+ Employee Benefit Expense	18.8	18.0	20.2	20.8	22.0	23.5	27.4	29.0	33.2	25.1	29.9	29.8
+ Finance Costs	24.1	25.1	22.0	21.5	21.8	22.6	23.7	21.5	18.6	18.2	16.7	16.9
+ Depreciation & Amortisation	32.4	29.6	32.1	32.4	32.3	34.9	36.2	35.6	35.5	36.5	37.4	37.0
+ Other Expenses	82.8	99.9	88.8	109.5	118.0	116.9	124.1	133.3	118.2	110.5	112.4	126.1
Total Expenses	370.3	448.0	423.8	476.5	432.1	538.4	486.6	553.8	507.4	596.0	568.1	614.6
EBITDA	90.0	91.0	94.4	110.2	112.8	132.6	132.1	182.0	151.3	180.2	152.3	199.8
EBIT	57.5	61.4	62.2	77.8	80.5	97.7	95.9	146.4	115.8	143.8	114.9	162.7
Profit
PBT before Exceptional Items	39.1	44.0	42.9	60.8	60.9	89.9	81.2	125.1	103.8	129.7	113.4	158.5
Pretax Income	39.1	44.0	42.9	60.8	60.9	89.9	81.2	125.1	103.8	129.7	113.4	158.5
+ Current Tax	10.2	10.3	11.0	16.0	16.4	25.2	24.9	35.5	29.0	34.5	30.2	42.1
+ Deferred Tax	0.1	1.7	0.5	-0.1	0.1	0.8	-1.3	-0.6	-0.0	1.1	0.3	-1.1
Tax Expense	10.3	12.1	11.5	15.9	16.4	26.0	23.6	34.9	28.9	35.6	30.5	41.0
Net Income	28.8	31.9	31.5	44.8	44.5	64.0	57.6	90.2	74.9	94.1	82.8	117.5
+ Net Income — Continuing Ops	28.8	31.9	31.5	44.8	44.5	64.0	57.6	90.2	74.9	94.1	82.8	117.5
+ Other Comprehensive Income	-1.5	0.1	-0.1	-0.2	0.5	-0.4	-0.5	0.7	-0.8	1.6	0.4	0.2
Total Comprehensive Income	27.2	32.0	31.4	44.7	45.0	63.6	57.1	90.9	74.1	95.7	83.2	117.7
Net Income to Common	27.2	31.9	31.5	44.7	44.4	—	61.9	—	78.0	94.1	84.2	117.0
Minority Interest	0.0	0.0	0.0	0.2	0.0	0.0	-4.4	0.0	-3.1	0.0	-1.4	0.5
Per Share
Basic EPS	7.37	8.16	8.05	11.43	11.38	17.03	15.85	24.04	19.97	23.99	21.56	29.96
Diluted EPS	7.37	8.16	8.05	11.43	11.38	0.00	15.85	24.04	19.97	23.99	0.00	29.96
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	-0.4	-0.5	0.7	-0.8	1.6	0.4	0.2
+ Items NOT to be Reclassified to P&L	0.1	0.1	-0.1	-0.2	-0.1	-0.6	-0.7	-0.8	-1.3	0.6	0.1	0.1
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	-0.1	-0.2	-0.2	-0.3	0.2	0.0	0.0
+ Tax on Items NOT to be Reclassified — alt tag	0.0	0.0	0.0	0.0	0.0	—	—	—	—	—	—	—
+ Items to be Reclassified to P&L	-1.7	0.0	0.0	0.1	0.5	0.0	0.0	1.3	0.2	1.1	0.3	0.1
Comprehensive Income — Owners of Parent	—	31.1	31.3	44.5	44.9	66.1	61.5	94.6	77.2	95.3	84.6	117.2
Comprehensive Income — Non-controlling Interests	—	0.8	0.1	0.2	0.0	-2.5	-4.4	-3.7	-3.1	0.4	-1.4	0.5
Per Share — as-filed variants
Basic EPS — Continuing Operations	7.37	8.16	8.05	11.43	11.38	17.03	15.85	24.04	19.97	23.99	21.56	29.96
Diluted EPS — Continuing Operations	7.37	8.16	8.05	11.43	11.38	0.00	15.85	24.04	19.97	23.99	0.00	29.96
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	191.7	208.9	203.4	240.5	252.8	273.1	283.6	344.4	302.7	315.9	294.6	355.7
Gross Margin %	47.47	43.13	43.83	45.14	51.49	44.51	50.74	50.74	50.07	43.78	44.22	46.77
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	39.1	44.0	42.9	60.8	60.9	89.9	81.2	125.1	103.8	129.7	113.4	158.5
Net Income Adj (tax-effected)	28.8	31.9	31.5	44.8	44.5	64.0	57.6	90.2	74.9	94.1	82.8	117.5
EPS Adj	7.37	8.16	8.05	11.43	11.38	17.03	15.85	24.04	19.97	23.99	21.56	29.96
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	—	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	39.1	39.1	39.1	39.1	39.1	39.1	39.1	39.1	39.1	39.1	39.1	39.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q2 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Privi Speciality Chemicals Q2 FY27 results (July–September 2026)

Privi Speciality Chemicals (NSE: PRIVISCL) reported its Q2 FY27 results (July–September 2026). Consolidated net profit attributable to shareholders was ₹117 crore, up 29.7% from ₹90.2 crore in Q2 FY26 and up 39.0% from ₹84.2 crore in Q1 FY27. Revenue from operations was ₹760 crore, up 12.0% year on year and up 14.1% from the previous quarter.

Q2 FY26 results (a year earlier): 5 November 2025
Q3 FY27 results due by: 14 February 2027

Q2 FY27 at a glance · consolidated

Net profit (shareholders'): ₹117 Cr+29.7% vs Q2 FY26+39.0% vs Q1 FY27Total incl. minority interest ₹118 Cr
Revenue from operations: ₹760 Cr+12.0% vs Q2 FY26+14.1% vs Q1 FY27
Operating margin (EBIT): 21.4%−0.2 pts vs Q2 FY26+4.2 pts vs Q1 FY27EBIT ₹163 Cr
EBITDA: ₹200 Cr+9.7% vs Q2 FY26+31.2% vs Q1 FY27margin 26.3%
Earnings per share (basic): ₹29.96+24.6% vs Q2 FY26+39.0% vs Q1 FY27
Net profit margin: 15.4%+2.1 pts vs Q2 FY26+2.7 pts vs Q1 FY27

Questions

What was Privi Speciality Chemicals' net profit in Q2 FY27?

Consolidated net profit attributable to shareholders was ₹117 crore, up 29.7% from ₹90.2 crore in Q2 FY26 and up 39.0% from ₹84.2 crore in Q1 FY27. Including the minority shareholders' share, total profit was ₹118 crore.

How were Privi Speciality Chemicals' Q2 FY27 results?

Both grew from a year earlier: net profit was up 29.7% at ₹117 crore and revenue was up 12.0% at ₹760 crore. The operating margin was 21.4%, down 0.2 percentage points from 21.6% a year earlier. Against Q1 FY27, net profit was up 39.0% and revenue up 14.1%.

What was Privi Speciality Chemicals' operating margin in Q2 FY27?

Operating profit (EBIT — revenue less operating expenses, before finance costs and other income) was ₹163 crore, a margin of 21.4%, against 17.2% in Q1 FY27 and 21.6% in Q2 FY26. EBITDA was ₹200 crore, 26.3% of revenue.

What was Privi Speciality Chemicals' revenue in Q2 FY27?

Revenue from operations was ₹760 crore, up 12.0% year on year and up 14.1% from the previous quarter.

What was Privi Speciality Chemicals' EPS in Q2 FY27?

Basic earnings per share were ₹29.96, against ₹24.04 in Q2 FY26.

What was Privi Speciality Chemicals' revenue in FY26?

Revenue from operations was ₹2,564 crore in FY26 (April 2025–March 2026), up 22.0% from ₹2,101 crore in FY25. It was ₹1,752 crore in FY24 and ₹1,608 crore in FY23: up 59.5% over three years, 16.8% a year on average.

What was Privi Speciality Chemicals' net profit in the first half of FY27?

Consolidated net profit attributable to shareholders for the first half of FY27 (April–September 2026) was ₹201 crore, up 32.3% from ₹152 crore in the same months a year earlier. Revenue from operations was ₹1,427 crore, up 15.3%.

What is Privi Speciality Chemicals' net profit margin?

Privi Speciality Chemicals' net profit margin was 15.4% in Q2 FY27 (net profit attributable to shareholders as a share of revenue from operations), against 13.3% in Q2 FY26 (up 2.1 percentage points). For FY26 as a whole it was 12.4%.

What was Privi Speciality Chemicals' net profit in FY26?

Consolidated net profit attributable to shareholders was ₹317 crore in FY26 (April 2025–March 2026), up 71.4% from ₹185 crore in FY25. It was ₹95.4 crore in FY24 and ₹24.6 crore in FY23: up 1,186.4% over three years, 134.3% a year on average.

How has Privi Speciality Chemicals' profit changed over the last four quarters?

Net profit attributable to shareholders by quarter: ₹78 crore in Q3 FY26, ₹94.1 crore in Q4 FY26, ₹84.2 crore in Q1 FY27 and ₹117 crore in Q2 FY27. That is ₹373 crore over the four quarters, up 43.3% from ₹261 crore in the four quarters before. Revenue from operations: ₹605 crore, ₹722 crore, ₹666 crore and ₹760 crore.

When will Privi Speciality Chemicals announce its Q3 FY27 results?

Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.

Where do these Privi Speciality Chemicals figures come from?

From Privi Speciality Chemicals' own consolidated results filings to NSE, in ₹ crore as filed. Growth compares the same consolidated figures a year and a quarter earlier.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.